Verdiva Bio

verdivabio.com

verdivabio.com • Startup • New

Startup • New

Actively hiring

Drug Discovery

Biotechnology

Cardiometabolic Therapeutics

Overview

Salaries

Products

People

Growth

Offices

Financials

Funding and backers

Backers

OrbiMed

Momentum

0/100

no fresh signals

Backed byfrom the funds' portfolios and accelerator catalogs

OrbiMed fund

Similar startupsby what they do, their industry and backers

Windward Bio

Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological…

Sparrow Pharmaceuticals51-200 employees

Sparrow Pharmaceuticals is an emerging clinical-stage biopharmaceutical company developing novel, targeted therapies for disorders of…

KaileraFounded 2024 • 51-200 employees • 6 roles

Kailera is a late clinical-stage biotechnology company advancing a diversified pipeline of GLP-1 therapies to provide options for people…

Curevo Vaccine51-200 employees

Curevo Vaccine is a clinical-stage biotech company dedicated to developing next-generation adjuvanted subunit vaccines to the market…

TerrestrialVenture round $57.3M · 6 mo ago • Founded 2012 • 51-200 employees • 14 roles

Terrestrial is transforming the delivery of next-generation therapies, starting with GLP-1. Terrestrial.

2026 Akero Therapeutics, Inc.

Akero Therapeutics is a clinical-stage company developing transformational therapies for people with metabolic dysfunction-associated…

Overview

Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related complications achieve better outcomes via more patient-friendly therapeutic options.